The CHIPS and Science Act represents a landmark US industrial policy to re-shore semiconductor manufacturing, driven by geopolitical competition with China and supply chain vulnerabilities exposed during the COVID-19 pandemic.
The Act's dual-incentive structure—a $39B grant program and a 25% investment tax credit—has successfully attracted investment commitments from all five leading-edge global chipmakers (TSMC, Samsung, Intel, SK Hynix, Micron) to build facilities in the US.
Despite success in the leading-edge sector, the policy has largely failed to attract mature node manufacturing due to intense price competition from Chinese overproduction, leaving a critical vulnerability for US defense and industrial supply chains.
Implementation has faced challenges, including companies underestimating the high costs of building in an atrophied US ecosystem and frustration with the slow, bureaucratic grant process, dubbed "the most expensive free money."
12 quotes
Concerns Raised
The CHIPS Act has failed to stimulate domestic manufacturing of mature node semiconductors, a critical vulnerability for defense and industrial sectors.
Chinese overproduction of mature node chips is creating market distortions that make US investment economically unviable without protectionist measures.
Companies underestimated the high costs and complexities of building fabs in the US, where the manufacturing ecosystem has atrophied.
The grant application process was bureaucratic and slow, with companies complaining it was the "most expensive free money" they had ever received.
US export controls, while slowing China, are also forcing Chinese firms to innovate in ways they otherwise would not, potentially creating new long-term competitors.
Opportunities Identified
The US has successfully attracted manufacturing commitments from all five leading-edge semiconductor companies, a feat no other country has achieved.
The policy has leveraged over $600 billion in private investment from an initial $39 billion government commitment, creating new manufacturing clusters.
The CHIPS Act provides a government 'stamp of approval' that de-risks projects for private customers and investors.
There is a growing bipartisan consensus on the strategic importance of the semiconductor industry, suggesting sustained policy focus.